As a classic chemical drug in anti-inflammatory therapy of IBD, 5-ASA can inhibit NF-κB signaling pathway to decrease inflammatory secretion, or restrain prostaglandin or leucotriene to eliminate inflammatory injury. The gene discussed is NFKB1; the disease is irritable bowel syndrome.